(Q35967532)

11 August 2017

1 reference

title

The ubiquitin system: pathogenesis of human diseases and drug targeting (English)

1 reference

11 August 2017

0 references

1

Aaron Ciechanover

1 reference

11 August 2017

Alan L Schwartz

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Biochimica et Biophysica Acta

11 August 2017

published in

1 reference

11 August 2017

volume

1695

1 reference

11 August 2017

issue

1-3

1 reference

11 August 2017

page(s)

3-17

1 reference

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

11 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/20459

Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Altered activity, social behavior, and spatial memory in mice lacking the NTAN1p amidase and the asparagine branch of the N-end rule pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

An essential role of N-terminal arginylation in cardiovascular development

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

First proteasome inhibitor approved for multiple myeloma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Polyglutamines placed into context

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Biosynthesis and degradation of CFTR.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The ubiquitin pathway in Parkinson's disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Orchestrating the unfolded protein response in health and disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Triplet repeat expansion in neuromuscular disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Aggresomes: a cellular response to misfolded proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Parkin is associated with actin filaments in neuronal and nonneural cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Proteasome inhibition: A novel mechanism to combat asthma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Ubiquitin, cellular inclusions and their role in neurodegeneration

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

RING finger proteins: mediators of ubiquitin ligase activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Identification of the receptor component of the IkappaBalpha-ubiquitin ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Genetic analysis of the role of the drosophila fat facets gene in the ubiquitin pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Stabilization of beta-catenin by genetic defects in melanoma cell lines

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Identification of ubiquitin ligases required for skeletal muscle atrophy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

UBE3A/E6-AP mutations cause Angelman syndrome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Impairment of the ubiquitin-proteasome system by protein aggregation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Antigen processing by the proteasome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Potential for proteasome inhibition in the treatment of cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Degradation of alpha-synuclein by proteasome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The role of ubiquitylation in signaling by growth factors: implications to cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Deregulated degradation of the cdk inhibitor p27 and malignant transformation.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Death and NF-kappaB in T cell activation: life at the edge

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Regulation of the epithelial sodium channel (ENaC) by accessory proteins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The Drosophila bendless gene encodes a neural protein related to ubiquitin-conjugating enzymes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Skp2 is oncogenic and overexpressed in human cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Activity and regulation of the centrosome-associated proteasome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Angelman syndrome: a review of clinical and genetic aspects

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

BRCA1-independent ubiquitination of FANCD2

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The p53-Mdm2 module and the ubiquitin system.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The role of the ubiquitin-proteasome pathway in the formation of mallory bodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Pharmacological treatment of the ion transport defect in cystic fibrosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

A conserved family of prolyl-4-hydroxylases that modify HIF

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Regulation of the Fanconi anemia pathway by monoubiquitination

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Identification of the familial cylindromatosis tumour-suppressor gene

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Characterization of the ubiquitin-specific protease activity of the mouse/human Unp/Unph oncoprotein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na(+) channel cell surface expression

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.BBAMCR.2004.09.018

Identifiers

DOI

10.1016/J.BBAMCR.2004.09.018

1 reference

11 August 2017

1 reference